ASCO Review- 2015 What is new in breast cancer?
Therapeutic antibodies 5_humanization
Phase II Trial of Gemcitabine and Docetaxel With Bevacizumab in Soft Tissue Sarcoma
Role of Vascular Endothelial Growth Factor (VEGF) in CRPC
Giorgio Mustacchi NSCLC: Targeting angiogenesis. NON-SMALL CELL LUNG CANCER.
Current Opinion in the Colorectal Cancer Treatment Dott. Carlo Garufi Oncologia Medica C Istituto Regina Elena – Roma [email protected].
AVADO
Final Overall Survival Results, Including Analysis of Patients with Triple-Negative Disease and Aged ≥70 Years, from the Athena Study Evaluating First-Line.
AVADO TRIAL David Miles Mount Vernon Cancer Centre, Middlesex, United Kingdom A randomized, double-blind study of bevacizumab in combination with docetaxel.
FOLFOX4 with or without Bevacizumab in Previously Treated Advanced Colorectal Cancer: Results from ECOG-E3200 Lee M Ellis, MD Colorectal Cancer Update.
An Oncology Exchange Activity Prior to the start of the program, please check your syllabus to ensure you have the following printed program materials:
TAP Vol 1 Issue 4
